North America Brain Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 151    |    Report Code: TIPRE00025904    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Brain Cancer Diagnostics Market

TABLE OF CONTENTS

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          North America Brain Cancer Diagnostics Market – By Country

2.           North America Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           North America Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- North America PEST Analysis

4.3          Expert Opinion

5.           North America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – North America Analysis

6.1          North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        North America: Brain Cancer Diagnostics Market

10.1.1        Overview

10.1.2        North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3        US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1          US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2          US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1           US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.3.3          US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.4          US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.4        Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1          Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2          Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.2.1           Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4.3          Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.4          Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5        Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1          Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2          Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1           Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.5.3          Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.4          Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market

11.1        North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        MDxHealth

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        NantOmics

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Biocept, Inc.

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Koninklijke Philips N.V.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Canon Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

13.9        Hitachi, Ltd.

13.9.1        Key Facts

13.9.2        Business Description

13.9.3        Products and Services

13.9.4        Financial Overview

13.9.5        SWOT Analysis

13.9.6        Key Developments

13.10     Neusoft Medical Systems

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 


LIST OF TABLES

Table 1.              US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3.              US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4.              US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.              Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 6.              Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 7.              Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 8.              Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.              Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 10.            Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11.            Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.            Organic Developments in the Brain Cancer Diagnostics Market

Table 14.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15.            Glossary of Terms, Brain Cancer Diagnostics Market

 


LIST OF FIGURES

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            North America Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - North America PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.          North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29.          US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.          Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.          Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.          Impact of COVID-19 Pandemic in North American Country Markets

Figure 33.          Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - North America Brain Cancer Diagnostics Market

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. MDxHealth
  5. NantOmics
  6. Biocept, Inc.
  7. Koninklijke Philips N.V
  8. Canon Medical Systems
  9. Hitachi, Ltd.
  10. Neusoft Medical Systems